Erratum to GLP-1 receptor agonists: a review of head-to-head clinical studies

Abstract

SAGE Publications wish to apologise for the following error which was introduced into “GLP-1 receptor agonists: a review of head-to-head clinical studies” by Jennifer M. Trujillo, Wesley Nuffer and Samuel L. Ellis. This article was published in Therapeutic Advances in Endocrinology and Metabolism 2015, volume 6(1) 19–28, DOI: 10.1177/2042018814559725.

Unfortunately when the figures were updated the captions were not. SAGE is extremely sorry for the inconvenience this error will cause to the authors and the readers. The correct figures and captions have been reproduced below.

Figure 1.

Change in A1C values with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in head-to-head clinical studies.

Figure 2.

Change in weight with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in head-to-head clinical studies.